Quinoline carboxylic acid derivatives and process for the preparation

Abstract

This invention relates to new compounds of value as antibacterial agent. More particularly, it relates to quinoline carboxylic acid derivatives, the hydrates and the salts thereof.

Description

FIELD OF THE INVENTION

This invention relates to new and useful quinoline carboxylic acid derivatives having potent antibacterial activities. Antibacterial agent's such as nalidixic acid, piromidic acid, and pipemidic acid have been proved highly effective in the therapy of infections due to gram-negative bacteria, but such agents suffer from the serious disadvantage of having only weak activities against most gram-positive bacteria and Pseudomonas aeruginosa.

It is therefore an object of this invention to provide a novel antibacterial agent and a novel preparation process therefore.

The compounds of the present invention are particularly useful in that they possess potent antibacterial activity against both Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa.

SUMMARY OF THE INVENTION

The present invention is to provide new compounds as defined below and their production processes

6,8-difluoro-1,4-dihydro-1-methyl-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid (I), 6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1-n-propylquinoline-3-carboxylic acid (II), 1-allyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid (III), 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid (IV), 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid (V), 7-(4-allyl-1-piperazinyl)-1-ethyl-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (VI), 1-ethyl-7-(4-ethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (VII), 1-ethyl-6,8-difluoro-1,4-dihydro-7-[4-(2-hydroxyethyl)-1-piperazinyl]-4-oxoquinoline-3-carboxylic acid (VIII), 1-ethyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxy-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid (IX), 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-hydroxy-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid (X), 1-ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-pyrrolidinyl)-quinoline-3-carboxylic acid (XI), 1-ethyl-6,8-difluoro-1,4-dihydro-7-(4-morpholinyl)-4-oxoquinoline-3-carboxylic acid (XII), 1-ethyl-6,8-difluoro-1,4-dihydro-7-(4-dimethylamino-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid (XIII), 6,8-difluoro-1,4-dihydro-1-(2-hydroxyethyl)-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid (XIV), 6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1-vinylquinoline-3-carboxylic acid (XV), and the hydrates and the pharmaceutically acceptable salts of these compounds.

The compounds of the present invention are prepared by the following methods.

The compounds (I-V, IX-XIII, and XIV) are prepared by the reaction of a compound of the formula (XVI) ##STR1## wherein R.sup.1 is methyl, ethyl, n-propyl, allyl, 2-fluoroethyl, or 2-hydroxyethyl group and X is halogen, with piperazine, N-methyl-piperazine, 3-hydroxypiperidine, pyrrolidine, morpholine, 4-dimethylaminopiperidine, or 4-hydroxypiperidine, in an inert solvent such as, for example, water, alcohols, pyridine, picoline, N,N-dimethylformamide, dimethylsulfoxide, or the like, or in the absence of a solvent, at a temperature in the range of 60.degree. C. to 180.degree. C.

The compounds (VI-VIII) are prepared by the treatment of 1-ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid or the salts, with allyl halide, ethyl halide, or 2-hydroxyethyl halide. The reaction is accomplished within several hours by heating in the range of room temperature to 150.degree. C. in an inert solvent such as, for example, water, alcohols, pyridine, picoline, N,N-dimethylformamide, dimethylsulfoxide, or the like, or in the absence of a solvent, in the presence of a base, as a dehydrohalogenating agent, such as alkali hydroxide, alkali carbonate, or amines.

The compound (XV) is obtained by the alkaline treatment of 7-(4-acetyl-1-piperazinyl)-1-(2-chloroethyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester.

The salts, such as, for example, sodium, potassium, calcium, magnesium, aluminum, ceric, chromic, cobaltic, cupric, ferric, silver, zinc, and organic base salts or hydrochlorides, sulfates, phosphates, acetates, lactates, and methanesulfonates, or the like, of the compounds of the present invention are obtained by the usual manner.

DETAILED DESCRIPTION OF THE INVENTION

The following examples serve to illustrate the invention.

EXAMPLE 1

6,8-Difluoro-1,4-dihydro-1-methyl-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid hydrochloride

A mixture of 6,7,8-trifluoro-1,4-dihydro-1-methyl-4-oxo-quinoline-3-carboxylic acid (0.22 g), piperazine (0.37 g), and pyridine (3 ml) was refluxed for 4 hours. The reaction mixture was evaporated to dryness. The residue was acidified by the addition of hot aqueous acetic acid solution and the insoluble materials were removed by filtration. The filtrate was adjusted to pH 1 with concentrated hydrochloric acid and cooled. The resulting precipitate was filtered off and recrystallized from water to give 6,8-difluoro-1,4-dihydro-1-methyl-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid hydrochloride (0.13 g), mp 286.degree.-288.degree. C. (decomp.).

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.15 H.sub.15 F.sub.2 N.sub.3 O.sub.3 HCl: 50.08 4.48 11.68Found: 49.98 4.38 11.58______________________________________

The starting material, 6,7,8-trifluoro-1,4-dihydro-1-methyl-4-oxoquinoline-3-carboxylic acid, was obtained by the following method.

A mixture of 6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester (0.3 g), anhydrous potassium carbonate (0.8 g), methyl iodide (1.6 g), and N,N-dimethyl-formamide (DMF) (10 ml) was heated with stirring at 90.degree.-100.degree. C. for 10 hours. The mixture was evaporated to dryness. The residue was treated with water, extracted with dichloromethane. The organic layer was washed with water, dried over anhydrous sodium sulfate, and evaporated. The residue was added to a mixture of 18% hydrochloric acid (5 ml) and ethanol (2.5 ml) and the mixture was refluxed for 2.5 hours. After water (5 ml) and ethanol (5 ml) added and cooled, the resulting precipitate was filtered off and recrystallized from a mixture of DMF and ethanol to give 6,7,8-trifluoro-1,4-dihydro-1-methyl-4-oxoquinoline-3-carboxylic acid (0.22 g), mp 255.degree.-258.degree. C.

EXAMPLE 2

6,8-Difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1-n-propylquinoline-3-carboxylic acid hydrochloride

A mixture of 6,7,8-trifluoro-1,4-dihydro-4-oxo-1-n-propyl-quinoline-3-carboxylic acid (0.22 g), piperazine )0.34 g), and pyridine (3 ml) was refluxed for 6 hours. The mixture was evaporated to dryness, adjusted to pH 1 with aqueous hydrochloric acid solution, and cooled. The solid was filtered off and recrystallized from water to afford 6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1-n-propylquinoline-3-carboxylic acid hydrochloride (0.11 g), mp 279.degree.-282.degree. C. (decomp.).

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.17 H.sub.19 F.sub.2 N.sub.3 O.sub.3 HCl: 52.65 5.20 10.83Found: 52.46 5.16 10.68______________________________________

The preparation of the starting material, 6,7,8-trifluoro-1,4-dihydro-4-oxo-1-n-propylquinoline-3-carboxylic acid (mp 202.degree.-205.degree. C.), and accomplished by the same method as described for that of the starting material in Example 1 by using n-propyl-bromide in place of methyl iodide.

EXAMPLE 3

1-Allyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid hydrochloride

A mixture of 1-allyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid (0.24 g), piperazine (0.37 g), and pyridine (3 ml) was refluxed for 6 hours. After the mixture evaporated to dryness, the residue was adjusted to pH 1 with diluted hydrochloric acid and cooled. The solid was filtered off and recrystallized from water to give 1-allyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl) quinoline-3-carboxylic acid hydrochloride (0.12 g), mp 278.degree.-281.degree. C. (decomp.).

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.17 H.sub.17 F.sub.2 N.sub.3 O.sub.3 HCl: 52.93 4.70 10.89Found: 52.65 4.68 10.82______________________________________

The starting material, 1-allyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (mp 194.degree.-197.degree. C.), was obtained by the same method as mentioned for the starting material in Example 1 by using allyl bromide instead of methyl iodide.

EXAMPLE 4

6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid hydrochloride

To a mixture of 6,7,8-trifluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (0.2 g) and piperazine (0.3 g) was added pyridine (5 ml) and the mixture was refluxed for 6 hours. The solvent was evaporated and the residue was strongly acidified with aqueous hydrochloric acid solution. After cooled, the solid was filtered off and recrystallized from water to give 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid hydrochloride (0.09 g), mp 291.degree.-294.degree. C. (decomp.).

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.16 H.sub.16 F.sub.3 N.sub.3 O.sub.3 HCl: 49.05 4.37 10.73Found: 49.04 4.36 10.68______________________________________

The starting material, 6,7,8-trifluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, was prepared by the method described below.

Anhydrous potassium carbonate (2.2 g), 6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester (0.8 g), 1-bromo-2-fluoroethane (3.8 g), sodium iodide (4.5 g), and DMF (30 ml) were combined and heated with stirring at 90.degree.-100.degree. C. for 10 hours. After the solvent evaporated and cooled, water was added to the residue and extracted with dichloromethane. The organic layer was washed with water, dried over anhydrous sodium sulfate, and evaporated. To the residual solid was added a mixture of 18% hydrochloric acid (14 ml) and ethanol (7 ml) and the acidic mixture was refluxed for 2.5 hours. Water (14 ml) and ethanol (14 ml) were added to the reaction mixture and cooled. The precipitate was collected by filtration and recrystallized from a mixture of DMF and ethanol to give 6,7,8-trifluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (0.34 g), mp 208.degree.-210.degree. C.

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.12 H.sub.7 F.sub.4 NO.sub.3 : 49.84 2.44 4.84Found: 49.86 2.37 5.01______________________________________

EXAMPLE 5

6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid hydrochloride

A mixed solution of 1-methylpiperazine (0.34 g) and pyridine (3 ml) was added to 6,7,8-trifluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (0.12 g) and heated to reflux for 6 hours. After the solvent evaporated and cooled, the residue was adjusted to pH 1 with aqueous hydrochloric acid. The cooled mixture was filtered off and the solid recrystallized from water to give 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid hydrochloride (0.08 g), mp 269.degree.-271.degree. C. (decomp.).

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.17 H.sub.18 F.sub.3 N.sub.3 O.sub.3 HCl: 50.32 4.72 10.36Found: 50.12 4.97 10.24______________________________________

EXAMPLE 6

7-(4-Allyl-1-piperazinyl)-1-ethyl-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid

A mixture of 1-ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3carboxylic acid hydrochloride (0.18 g), triethylamine (0.12 g), allyl bromide (0.09 g), and DMF (3 ml) was heated with stirring at 90.degree. for 3 hours and the solvent was evaporated. The residue was dissolved in 2N sodium hydroxide solution. The alkaline solution was adjusted to pH 7 with aqueous acetic acid and extracted with dichloromethane. The organic layer was washed with water, dried over anhydrous sodium sulfate, and evaporated. The residue was recrystallized from a mixture of DMF and ethanol to give 7-(4-allyl-1-piperazinyl)-1-ethyl-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (0.055 g), mp 227.degree.-230.degree. C. (decomp.).

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.19 H.sub.21 F.sub.2 N.sub.3 O.sub.3 1/4H.sub.2 59.76 5.67 11.00Found: 59.69 5.52 10.89______________________________________

EXAMPLE 7

1-Ethyl-7-(4-ethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid

Triethylamine (0.2 g), 1-ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid hydrochloride (0.3 g), ethyl iodide (0.19 g), and DMF (5 ml) were mixed, heated with stirring at 90.degree. C. for 3 hours, and the solvent was evaporated. The residue was dissolved in 2N sodium hydroxide solution. The alkaline solution was neutralized with aqueous acetic acid and extracted with dichloromethane. The dichloromethane layer was washed with water, dried over anhydrous sodium sulfate, and evaporated. The residue was recrystallized from a mixture of DMF and ethanol to give 1-ethyl-7-(4-ethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (0.06 g), mp 236.degree.-239.degree. C.

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.18 H.sub.21 F.sub.2 N.sub.3 O.sub.3 1/4H.sub.2 58.45 5.86 11.36Found: 58.38 5.74 11.31______________________________________

EXAMPLE 8

1-Ethyl-6,8-difluoro-1,4-dihydro-7-[4-(2-hydroxyethyl)-1-piperazinyl]-4-oxoquinoline-3-carboxylic acid

A mixture of 1-ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid hydrochloride (0.3 g), triethylamine (0.2 g), 2-bromoethanol (0.15 g), and DMF (5 ml) was heated with stirring at 90.degree. C. for 3 hours. After the solvent evaporated, the residue was dissolved in 2N sodium hydroxide solution, neutralized with aqueous acetic acid, and extracted with dichloromethane. The organic layer was washed with water, dried over anhydrous sodium sulfate, and evaporated. The solid was recrystallized from a mixture of DMF and ethanol to give 1-ethyl-6,8-difluoro-1,4-dihydro-7-[4-(2-hydroxyethyl)-1-piperazinyl]-4-oxoquinoline-3-carboxylic acid (0.08 g), mp 225.degree.-228.degree. C.

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.18 H.sub.21 F.sub.2 N.sub.3 O.sub.4 : 56.69 5.55 11.02Found: 56.43 5.62 10.93______________________________________

EXAMPLE 9

1-Ethyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxy-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid

To a solution of pyridine (3 ml) and 4-hydroxy-piperidine (1.6 g), 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (0.43 g) was added and the mixture was heated to reflux for 6 hours. After the solvent evaporated off, the residue was treated with water, acidified wth acetic acid and extracted with dichloro methane. The organic layer was washed with water, dried over anhydrous sodium sulfate, and evaporated. The residue was recrystallized from a mixture of DMF and ethanol to afford 1-ethyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxy-1-piperidinyl-4-oxoquinoline-3-carboxylic acid (0.42 g), mp 216.degree.-218.degree. C.

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.17 H.sub.18 F.sub.2 N.sub.2 O.sub.4 1/4H.sub.2 57.22 5.23 7.85Found: 57.41 5.01 8.03______________________________________

EXAMPLE 10

1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-hydroxy-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid

A mixture of 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid (0.43 g), 3-hydroxypiperidine (1.6 g), and pyridine (3 ml) was refluxed for 6 hours. The mixture was evaporated to dryness, treated with water, acidified with acetic acid, and extracted with dichloromethane. The dichloromethane layer was washed with water, dried over anhydrous sodium sulfate, and evaporated. The residue was recrystallized from a mixture of DMF and ethanol to give 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-hydroxy-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid (0.3 g), mp 232.degree.-234.degree. C.

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.17 H.sub.18 F.sub.2 N.sub.2 O.sub.4 1/4H.sub.2 57.22 5.23 7.85Found: 57.18 5.13 7.97______________________________________

EXAMPLE 11

1-Ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-pyrrolidinyl)quinoline-3-carboxylic acid

A mixture of 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid (0.43 g), pyrrolidine (1.2 g), and pyridine (3 ml) was refluxed for 6 hours. The solvent was evaporated off. The residue was treated with water, acidified with acetic acid, and extracted with dichloromethane. The organic layer was washed with water, dried over anhydrous sodium sulfate, and evaporated. The solid was recrystallized from a mixture of DMF and ethanol and gave 1-ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-pyrrolidinyl)quinoline-3-carboxylic acid (0.34 g), mp 284.degree.-286.degree. C. (decomp.).

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.16 H.sub.16 F.sub.2 N.sub.2 O.sub.3 1/4H.sub.2 58.80 5.09 8.57Found: 58.54 4.87 8.62______________________________________

EXAMPLE 12

1-Ethyl-6,8-difluoro-1,4-dihydro-7-(4-morpholinyl)4-oxoquinoline-3-carboxylic acid

A mixture of 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (0.43 g), morpholine (1.4 g), and pyridine (3 ml) was refluxed for 6 hours. After the mixture evaporated to dryness, the residue was acidified with aqueous acetic acid and extracted with dichloromethane. The organic layer was washed with water, dried, and evaporated. The solid was recrystallized from a mixture of DMF and ethanol and gave 1-ethyl-6,8-difluoro-1,4-dihydro-7-(4-morpholinyl)-4-oxoquinoline-3-carboxylic acid (0.28 g), mp 268.degree.-271.degree. C. (decomp.).

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.16 H.sub.16 F.sub.2 N.sub.2 O.sub.4 1/4H.sub.2 56.06 4.85 8.17Found: 56.27 4.65 8.32______________________________________

EXAMPLE 13

1-Ethyl-6,8-difluoro-1,4-dihydro-7-(4-dimethylamino-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid

A mixture of 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (0.43 g), 4-dimethylaminopiperidine (2.1 g), and pyridine (3 ml) was refluxed for 6 hours. The mixture was evaporated to dryness. The residue was treated with water and extracted with dichloromethane. The organic layer was washed with water, dried, and evaporated. The solid was recrystallized from ethyl acetate and gave 1-ethyl-6,8-difluoro-1,4-dihydro-7-(4-dimethylamino-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid (0.22 g), mp 210.degree.-211.degree. C.

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.19 H.sub.23 F.sub.2 N.sub.3 O.sub.3 1/4H.sub.2 59.44 6.17 10.95Found: 59.44 6.01 10.77______________________________________

EXAMPLE 14

6,8-Difluoro-1,4-dihydro-1-(2-hydroxyethyl)-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid hydrochloride

A mixture of 6,7,8-trifluoro-1,4-dihydro-1-(2-hydroxyethyl)-4-oxoquinoline-3-carboxylic acid (0.14 g), piperazine (0.22 g), and pyridine (3 ml) was refluxed for 6hours. After the mixture evaporated to dryness, the residue was strongly acidified with aqueous hydrochloric acid and cooled. The solid was filtered off and recrystallized from water to give 6,8-difluoro-1,4-dihydro-1-(2-hydroxyethyl)-4-oxo-7-(1-piperazinyl) quinoline-3-carboxylic acid hydrochloride (0.05 g), mp 298.degree.-300.degree. C. (decomp.).

______________________________________ C H N______________________________________Anal. Calcd. for C.sub.16 H.sub.17 F.sub.2 N.sub.3 O.sub.4 HCl: 49.30 4.65 10.78Found: 48.94 4.50 10.76______________________________________

The starting material, 6,7,8-trifluoro-1,4-dihydro-1-(2-hydroxyethyl)-4-oxoquinoline-3-carboxylic acid, was prepared as described for the starting material in Example 1 by using 2-bromoethanol instead of methyl iodide.

EXAMPLE 15

6,8-Difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1-vinylquinoline-3-carboxylic acid hydrochloride

To a solution of sodium hydroxide (0.2 g), water (2.5 ml), and ethanol (2.5 ml), 7(4-acetyl-1-piperazinyl)-1-(2-chloroethyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester (0.2 g) was added and the mixture was heated with stirring at 80.degree.-90.degree. C. for 3 hours. After cooled, the reaction mixture was strongly acidified with concentrated hydrochloric acid.

The precipitate was filtered off and recrystallized from water to give 6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1-vinylquinoline-3-carboxylic acid hydrochloride, mp 267.degree.-270.degree. C. (decomp.); mass spectrum, m/e 335 (M.sup.+ -HCl).

The starting material, 7-(4acetyl-1-piperazinyl)-1-(2-chloroethyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester, was prepared by the following method.

A mixture of 6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester (4.1 g), anhydrous potassium carbonate (5.2 g), 2-bromoethanol (9.5 g), and DMF (90 ml) was stirred at 100.degree. C. for 10 hours. After the mixture evaporated to dryness, the residue was treated with water, extracted with dichloromethane, washed with water, dried, and evaporated.

The solid was recrystallized from ethanol to give 6,7,8-trifluoro-1,4-dihydro-1-(2-hydroxyethyl)-4-oxoquinoline-3-carboxylic acid ethyl ester (mp 175.degree.-177.degree. C.).

A mixture of the above 1-(2-hydroxyethyl)quinoline ester (1.2 g), piperazine (1.7 g), and pyridine (10 ml) was refluxed for 4 hours. After the mixture evaporated to dryness, the residue was treated with water, made basic with potassium carbonate, and extracted with dichloromethane. The organic layer was washed with water, dried, and evaporated to give 6,8-difluoro-1,4-dihydro-1-(2-hydroxyethyl)-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid ethyl ester.

To a solution of the above 7-(1-piperazinyl) quinoline ester (1.1 g) and acetic acid (6.5 ml), acetic anhydride (0.4 g) was added and the mixture was stirred at 80.degree. C. for 1 hours. After the solvent was evaporated, the residue was treated with water and extracted with dichloromethane. The organic layer was washed with water, dried, and evaporated to give 7-(4-acetyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-1-(2-hydroxyethyl)-4-oxoquinoline-3-carboxylic acid ethyl ester.

To an ice-cooled solution of the above 7-(4-acetyl-1-piperazinyl)quinoline ester (1.0 g), pyridine (0.27 g), and chloroform (30 ml), a solution of thionylchloride (3.2 g) and chloroform (13 ml) was added dropwise. The mixture was stirred at room temperature for 15 hours. The solvent was evaporated.

The residue was made weakly basic with aqueous potassium carbonate, extracted with chloroform, washed with water, dried, and evaporated. The residue was purified by chromatography on alumina with chloroform as the eluting agent to give 7-(4-acetyl-1-piperazinyl)-1-(2-chloroethyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethyl ester.

EXAMPLE 16

1-Ethyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxy-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid silver salt

To a stirred solution of 1-ethyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxy-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid (235 mg), sodium hydroxide (26.7 mg), and water (3 ml), a solution of silver nitrate (113 mg) and water (2 ml) was added. The precipitate was filtered off, washed with water, and dried to give 1-ethyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxy-1-piperidinyl)-4-oxoquinoline-3-carboxylic acid silver salt (284 mg), mp 181.degree.-184.degree. C. (decomp.).

Experiment 1 Antibacterial Activity

The antibacterial activities of the compounds of the present invention were assayed by the standard agar dilution streak method against Gram-positive and Gram-negative bacteria [Chemotherapy, 22, 1126 (1974)]. The result was shown in Table 1.

TABLE 1__________________________________________________________________________Antibacterial Activity__________________________________________________________________________ Minimum inhibitory concentration (.mu.g/ml) Ex. Ex. Ex. Ex. Ex. Ex. Ex. Ex.Organisms 1 2 3 4 5 6 7 8__________________________________________________________________________Bacillus subtilis PCI 219 0.39 0.20 0.39 0.39 0.10 0.10 0.10 0.10Staphylococcus aureus 209 p 3.13 1.56 3.13 3.13 0.78 0.78 0.78 0.78S. aureus Terajima 3.13 3.13 3.13 3.13 0.78 0.78 0.78 0.78S. epidermidis IID 866 3.13 3.13 3.13 1.56 0.78 0.78 0.78 0.78Escherichia coli NIHJ JC-2 .ltoreq.0.05 .ltoreq.0.05 0.10 .ltoreq.0.05 .ltoreq.0.05 0.10 .ltoreq.0.05 .ltoreq.0.05E. coli ATCC 10536 0.10 0.20 0.39 0.10 0.10 0.39 0.10 0.20Proteus vulgaris 3167 0.10 .ltoreq.0.05 0.10 .ltoreq.0.05 .ltoreq.0.05 0.20 .ltoreq.0.05 0.10P. mirabilis IID 994 0.10 0.10 0.20 .ltoreq.0.05 .ltoreq.0.05 0.39 0.20 0.20P. morganii IID 602 0.20 0.39 0.39 0.20 0.10 0.78 0.39 0.78Klebsiella pneumoniae IFO 3512 .ltoreq.0.05 0.10 0.10 .ltoreq.0.05 .ltoreq.0.05 .ltoreq.0.05 .ltoreq.0.05 .ltoreq.0.05Enterobacter cloacae IID 977 0.10 0.78 0.78 .ltoreq.0.05 0.10 1.56 0.39 0.39Citrobacter freundii IID 976 .ltoreq.0.05 0.20 0.20 .ltoreq.0.05 .ltoreq.0.05 0.78 0.20 0.39Serratia marcescens IID 618 0.10 0.39 0.39 0.39 0.10 1.56 0.39 0.78Shigella sonnei IID 969 .ltoreq.0.05 0.10 0.10 .ltoreq.0.05 .ltoreq.0.05 0.20 0.10 0.10Salmonella enteritidis IID 604 0.10 0.20 0.20 0.05 0.10 1.56 0.39 0.78Yersinia enterocolitica 0.10 0.39 0.39 0.05 0.10 0.78 0.20 0.39IID 981Pseudomonas aeruginosa V-1 3.13 12.5 12.5 6.25 3.13 12.5 6.25 12.5P. aeruginosa IFO 12689 1.56 6.25 6.25 1.56 3.13 25 6.25 12.5Acinetobacter anitratus IID 876 1.56 1.56 3.13 3.13 0.39 0.78 0.39 1.56Alcaligenes faecalis 0104002 6.25 1.56 3.13 3.13 0.78 3.13 1.56 1.56__________________________________________________________________________ Minimum inhibitory concentration (.mu.g/ml) Ex. Ex. Ex. Ex. Ex. Ex. Ex.Organisms 9 10 11 12 13 14 16__________________________________________________________________________Bacillus subtilis PCI 219 .ltoreq.0.05 .ltoreq.0.05 .ltoreq.0.05 .ltoreq. 0.05 0.10 3.13 .ltoreq.0.05Staphylococcus aureus 209 p 0.20 0.20 0.10 0.20 0.39 12.5 0.20S. aureus Terajima 0.20 0.39 0.10 0.39 0.39 25 0.39S. epidermidis IID 866 0.39 0.78 0.20 0.39 0.39 12.5 0.39Escherichia coli NIHJ JC-2 0.20 0.39 0.20 0.20 .ltoreq.0.05 0.39 0.78E. coli ATCC 10536 0.20 0.78 0.20 0.39 0.20 0.39 0.78Proteus vulgaris 3167 .ltoreq.0.05 0.10 .ltoreq.0.05 .ltoreq.0.05 0.10 0.39 0.10P. mirabilis IID 994 0.39 0.10 0.20 0.39 1.56 0.39P. morganii IID 602 0.78 1.56 0.39 0.78 1.56 1.56 1.56Klebsiella pneumoniae IFO 3512 .ltoreq.0.05 0.10 .ltoreq.0.05 .ltoreq.0.05 .ltoreq.0.05 0.39 0.10Enterobacter cloacae IID 977 1.56 6.25 1.56 1.56 3.13 0.39 3.13Citrobacter freundii IID 976 0.78 1.56 0.39 0.78 0.39 0.20 1.56Serratia marcescens IID 618 1.56 3.13 1.56 1.56 0.78 6.25 3.13Shigella sonnei IID 969 0.20 0.78 0.20 0.20 0.10 0.20 0.39Salmonella enteritidis IID 604 1.56 6.25 1.56 1.56 0.78 0.39 1.56Yersinia enterocolitica 0.78 1.56 0.39 0.39 0.78 0.39 1.56IID 981Pseudomonas aeruginosa V-1 6.25 25 6.25 12.5 12.5 1.56 3.13P. aeruginosa IFO 12689 12.5 25 6.25 12.5 25 12.5 25Acinetobacter anitratus IID 876 1.56 1.56 0.39 1.56 0.78 25 1.56Alcaligenes faecalis 0104002 1.56 3.13 0.39 1.56 6.25 100 3.13__________________________________________________________________________

Claims

1. 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid, the hydrates, or the pharmaceutically acceptable salts thereof.

2. 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid, the hydrates, or the pharmaceutically acceptable salts thereof.

3. 6,8-Difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1-vinylquinoline-3-carboxylic acid, the hydrates, or the pharmaceutically acceptable salts thereof.